Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens

Overview of attention for article published in Journal of Translational Medicine, May 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 1,289,653 followers.

Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens https://t.co/Uk5wtvuNqP

RT @medical_xpress: Researchers find a new class of biomarkers to predict treatment outcomes in ##cancerpatients https://t.co/4rIAyRV4dM ht…

RT @medical_xpress: Researchers find a new class of biomarkers to predict treatment outcomes in ##cancerpatients https://t.co/4rIAyRV4dM ht…

RT @medical_xpress: Researchers find a new class of biomarkers to predict treatment outcomes in ##cancerpatients https://t.co/4rIAyRV4dM ht…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.